共 20 条
Multicenter, randomized study to optimize bowel for colon capsule endoscopy
被引:13
作者:
Kastenberg, David
[1
]
Burch, Wilmot C., Jr.
[2
]
Romeo, David P.
[3
]
Kashyap, Pankaj K.
[4
]
Pound, David C.
[5
]
Papageorgiou, Neophytos
[6
]
Fernandez-Urien Sainz, Ignacio
[7
]
Sokach, Carly E.
[8
]
Rex, Douglas K.
[9
]
机构:
[1] Thomas Jefferson Univ, Div Gastroenterol, Philadelphia, PA 19107 USA
[2] Franklin Gastroenterol PLLC, Franklin, TN 37067 USA
[3] Dayton Gastroenterol Inc, Beavercreek, OH 45540 USA
[4] Pinnacle Res Grp LLC, Anniston, AL 36207 USA
[5] Indianapolis Gastroenterol & Hepatol, Indianapolis, IN 46237 USA
[6] Amer Med Ctr, Dept Gastroenterol, CY-1311 Nicosia, Cyprus
[7] Hosp Navarra, Dept Gastroenterol, Serv Digest, Pamplona 31001, Spain
[8] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[9] Indiana Univ Hosp, 550 N Univ Blvd, Indianapolis, IN 46202 USA
关键词:
Bowel preparation;
Purgative;
Capsule endoscopy;
Endoscopy;
Capsule colonoscopy;
Large intestine;
COLORECTAL-CANCER;
SODIUM-PHOSPHATE;
RENAL-FAILURE;
COLONOSCOPY;
POLYPS;
ACCURACY;
GASTROGRAFIN;
SURVEILLANCE;
1ST;
D O I:
10.3748/wjg.v23.i48.8615
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
AIM To assess the cleansing efficacy and safety of a new Colon capsule endoscopy (CCE) bowel preparation regimen. METHODS This was a multicenter, prospective, randomized, controlled study comparing two CCE regimens. Subjects were asymptomatic and average risk for colorectal cancer. The second generation CCE system (PillCam (R) COLON 2; Medtronic, Yoqneam, Israel) was utilized. Preparation regimens differed in the 1st and 2nd boosts with the Study regimen using oral sulfate solution (89 mL) with diatrizoate meglumine and diatrizoate sodium solution ("diatrizoate solution") (boost 1 = 60 ml, boost 2 = 30 ml) and the Control regimen oral sulfate solution (89 mL) alone. The primary outcome was overall and segmental colon cleansing. Secondary outcomes included safety, polyp detection, colonic transit, CCE completion and capsule excretion <= 12 h. RESULTS Both regimens had similar cleansing efficacy for the whole colon (Adequate: Study = 75.9%, Control = 77.3%; P = 0.88) and individual segments. In the Study group, CCE completion was superior (Study = 90.9%, Control = 76.9%; P = 0.048) and colonic transit was more often < 40 min (Study = 21.8%, Control = 4%; P = 0.0073). More Study regimen subjects experienced adverse events (Study = 19.4%, Control = 3.4%; P = 0.0061), and this difference did not appear related to diatrizoate solution. Adverse events were primarily gastrointestinal in nature and no serious adverse events related either to the bowel preparation regimen or the capsule were observed. There was a trend toward higher polyp detection with the Study regimen, but this did not achieve statistical significance for any size category. Mean transit time through the entire gastrointestinal tract, from ingestion to excretion, was shorter with the Study regimen while mean colonic transit times were similar for both study groups. CONCLUSION A CCE bowel preparation regimen using oral sulfate solution and diatrizoate solution as a boost agent is effective, safe, and achieved superior CCE completion.
引用
收藏
页码:8615 / 8625
页数:11
相关论文